Actively Recruiting
Efficacy Of Hiatal Closure For GERD
Led by University of Chicago · Updated on 2026-02-02
40
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.
CONDITIONS
Official Title
Efficacy Of Hiatal Closure For GERD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 - 50 years
- Able to provide informed consent
- BMI <30
- Hiatal defect <4cm on esophagram
- pH testing showing acid exposure (pH <4) for >5.5% of the time
- Surgical candidate for hiatal closure only
You will not qualify if you...
- Vulnerable subjects such as children, prisoners, and pregnant women will be excluded.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Chicago
Chicago, Illinois, United States, 60637
Actively Recruiting
Research Team
Y
Yalini Vigneswaran, MD
CONTACT
J
John Alverdy, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here